Waldencast Acquisition Corp. Warrant (NASDAQ:WALDW)
| Market Cap | 24.04M-86.5% |
| Revenue (ttm) | 272.07M+42.1% |
| Net Income | -229.75M-31.7% |
| EPS | -2.02-31.3% |
| Shares Out | 114.08M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,263,738 |
| Open | 0.86 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.86 |
| 52-Week Range | 0.00 - 0.86 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About WALDW
Waldencast plc specializes in sophisticated skincare solutions, offering advanced treatments designed to diminish the appearance of premature aging, alleviate skin damage, correct hyperpigmentation, manage acne, and mitigate the effects of sun exposure. These products are predominantly distributed through a professional network that includes dermatologists, plastic surgeons, medical spas, and other certified skincare experts. The company's portfolio features Obagi Medical, a line of transformative skincare products formulated to visibly reduce signs of aging, target issues such as dark spots, uneven pigmentation, fine lines, and wrinkles, while simultaneously safeguarding and enhancing overall skin tone and texture. Additionally, Obagi Clinical provides skincare offerings specifically developed to proactively prevent the onset of early aging symptoms. Established in 1988, the company is based in White Plains, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$WALDW stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in WALDW holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by WALDW's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
WALDW Estimated quarterly lobbying spending
Source: U.S. Senate LDA
WALDW Revenue by Segment or Geography
As of: Q1 2022 (Mar 31, 2022) · Source: SEC EDGAR (10-Q)
U.S. Patents
New WALDW patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to WALDW from public contracts
Source: USAspending.gov
WALDW Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from WALDW’s recent data — informational, not investment advice